The frequent over‐expression of PRMT5 in diverse human tumours, which includes neuroblastoma [17], and the critical role ascribed to E2F1 in the cancer cell cycle [11] suggests that PRMT5 and E2F1 may play an important role in driving the malignant phenotype. This evidence concerns the gene PRMT5 and neuroblastoma.